European Urology published a clinical update in Research Highlights on 02 Apr 2026. The item focuses on Re: Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette-Guérin–naïve Non–muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301). Review the original article for the full source wording and details.
Hayne D, Zhang AY, Thomas H, et al